Stifel Nicolaus Sticks to Its Buy Rating for IGM Biosciences (IGMS)
TipRanksApr 18 14:25 ET
IGM Biosciences Price Target Maintained With a $12.00/Share by HC Wainwright & Co.
IGM Biosciences Price Target Maintained With a $12.00/Share by HC Wainwright & Co.
Dow JonesApr 18 06:43 ET
Express News | HC Wainwright & Co. Reiterates Neutral on IGM Biosciences, Maintains $12 Price Target
Moomoo 24/7Apr 18 06:33 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: IGM Biosciences (IGMS) and Argenx Se (ARGX)
TipRanksApr 18 06:30 ET
Why IGM Biosciences Is Rising In Pre-market?
RTTNewsApr 17 09:24 ET
Express News | IGM Biosciences Announces Worldwide Collaboration Agreement With Sanofi To Create And Develop IgM Agonist Antibodies Will Focus Exclusively On Immunology/Inflammation Targets
Moomoo 24/7Apr 17 08:33 ET
Express News | IGM Biosciences: Under Agreement, Will Be Eligible to Receive up to $1,065 Mln in Aggregate Development, Regulatory and Commercial Milestones/Target
Moomoo 24/7Apr 17 08:32 ET
Express News | IGM Biosciences Inc: Will Retain Global Rights to Its Proprietary Technology Related to Oncology Targets Nominated by Sanofi Under Collaboration
Moomoo 24/7Apr 17 08:31 ET
Express News | IGM Biosciences Inc: Agreement With Sanofi to Create and Develop IGM Agonist Antibodies Will Now Focus Exclusively on Immunology/Inflammation Targets
Moomoo 24/7Apr 17 08:31 ET
Express News | IGM Biosciences Announces Refocusing of Sanofi Collaboration
Moomoo 24/7Apr 17 08:30 ET
IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
MOUNTAIN VIEW, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announ
GlobeNewswireApr 10 07:00 ET
IGM Biosciences(IGMS.US) 10% Shareholder Buys US$3.43 Million in Common Stock
$IGM Biosciences(IGMS.US)$ 10% Shareholder BAKER BROS. ADVISORS LP purchased 395.32K shares of Common Stock on Mar 26, 27, 28, 2024 at an average price of $8.6654 for a total value of $3.43 million. T
moomoo NewsMar 28 19:44 ET
Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Alpine Immune Sciences (ALPN) and IGM Biosciences (IGMS)
TipRanksMar 19 08:50 ET
Have Insiders Sold IGM Biosciences Shares Recently?
We note that the IGM Biosciences, Inc. (NASDAQ:IGMS) CEO, President & Director, Fred Schwarzer, recently sold US$90k worth of stock for US$10.01 per share. On the bright side, that's just a small s
Simply Wall StMar 18 06:45 ET
IGM Biosciences Price Target Raised to $12.00/Share From $7.00 by HC Wainwright & Co.
IGM Biosciences Price Target Raised to $12.00/Share From $7.00 by HC Wainwright & Co.
Dow JonesMar 12 06:55 ET
IGM Biosciences Is Maintained at Neutral by HC Wainwright & Co.
IGM Biosciences Is Maintained at Neutral by HC Wainwright & Co.
Dow JonesMar 12 06:55 ET
IGM Biosciences: A Balanced Hold Rating Amid Financial Stability and Drug Development Risks
TipRanksMar 12 06:27 ET
IGM Biosciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Yahoo FinanceMar 9 08:16 ET
IGM Biosciences Price Target Maintained With a $21.00/Share by RBC Capital
IGM Biosciences Price Target Maintained With a $21.00/Share by RBC Capital
Dow JonesMar 8 11:31 ET
Express News | Wedbush Reiterates Outperform on IGM Biosciences, Maintains $20 Price Target
Moomoo 24/7Mar 8 10:11 ET
No Data
No Data